IFP Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32K Buy
674
+646
+2,307% +$1.51K ﹤0.01% 4107
2025
Q4
$76 Sell
28
-28
-50% -$92 ﹤0.01% 4647
2025
Q3
$237 Buy
+56
New +$246 ﹤0.01% 4363
2025
Q2
Hold
0
3682
2025
Q1
Hold
0
4151
2024
Q4
Hold
0
4432
2023
Q3
Sell
-53
Closed -$292 3397
2023
Q2
$292 Sell
53
-13
-20% -$70 ﹤0.01% 3272
2023
Q1
$3.33K Sell
66
-96
-59% -$535 ﹤0.01% 2724
2022
Q4
$10K Sell
162
-3,189
-95% -$15.7K ﹤0.01% 3377
2022
Q3
$172K Hold
3,351
﹤0.01% 1501
2022
Q2
$172K Hold
3,351
0.01% 1358
2022
Q1
$172K Buy
3,351
+2,188
+188% +$50.2K 0.01% 1358
2021
Q4
$41K Buy
1,163
+873
+301% +$35.1K ﹤0.01% 1630
2021
Q3
$15K Sell
290
-60
-17% -$2.18K ﹤0.01% 2110
2021
Q2
$14K Buy
350
+176
+101% +$6.5K ﹤0.01% 2082
2021
Q1
$6K Buy
174
+99
+132% +$4.45K ﹤0.01% 2340
2020
Q4
$2K Buy
+75
New +$3.45K ﹤0.01% 2613

Other funds holding GDRX

IFP Advisors's GDRX Position: Q1 2026 in Review

IFP Advisors increased its GoodRx Holdings (GDRX) stake by 2,307% in Q1 2026, buying an estimated $1.51K and bringing the position to 674 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #4107.

IFP Advisors first reported a position in GDRX in Q4 2020 and has held it in 14 quarters since. The position peaked at $172K in Q3 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • IFP Advisors held 674 shares of GoodRx Holdings worth $1.32K as of Q1 2026.
  • IFP Advisors bought 646 GoodRx Holdings shares in Q1 2026, an estimated $1.51K.
  • GoodRx Holdings made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4107 holding.
  • IFP Advisors first reported a position in GoodRx Holdings in Q4 2020 and has held it in 14 quarters since.
  • IFP Advisors's GoodRx Holdings position peaked at $172K in Q3 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.